A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations
Clinical trial NCT07472907 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07472907
- Sponsor
- Cilcare SAS
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-07-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.